Skip to main content
. 2014 Jun 4;14:404. doi: 10.1186/1471-2407-14-404

Table 2.

Data assessment schedule in the PROLUCA trial

  Baseline a Flw-up b Flw-up c Flw-up d Flw-up e Flw-up f
Anthropometric data and cancer disease
 X
 X
  
 X
 X
 X
 
 Physiological measurements
  
  
  
  
Cardiorespiratory capacity (VO2peak)
 X
 X
  
 X
 X
 X
Six- minute walk distance (6MWD)
 X
 X
 X
 X
 X
 X
One-repetition-maximum (1RM)
 X
 X
  
 X
 X
 X
Heart rate (HR), Blood pressure (BP)
 X
 X
  
 X
 X
 X
Spirometric (FEV1/FEV1%)
 X
 X
  
 X
 X
 X
 
 Patient-reported outcome
  
  
  
  
Health-related quality of life (EORTC QLQ-C30, FACT-L)
 X
 X
 FACT-L
 X
 X
 X
Symptoms and side effects (EORTC–LC13)
 X
 X
  
 X
 X
 X
Anxiety and depression (HADS)
 X
 X
  
 X
 X
 X
Well-being (SF-36)
 X
 X
  
 X
 X
 X
Distress thermometer
 X
 X
  
 X
 X
 X
Lifestyle
 X
 X
  
 X
 X
 X
Sickness absence and work status
 X
 X
  
 X
 X
 X
Social support (MSPSS)
 X
 X
  
 X
 X
 X
 
 Other measurements
  
  
  
  
Perioperative complications
 X (30 days)
 X (30 days)
  
  
  
  
Duration of hospitalization
 X (30 days)
 X (30 days)
  
  
  
  
Survival Histological diagnosis and TNM staging           X

aBaseline (0 week).

bFlw-up (Follow-up): Preoperation (the day before surgery).

cFlw-up (Follow-up): Pre-intervention (2/6 weeks after surgery).

dFlw-up (Follow-up): Post-intervention (14/18 weeks after surgery).

eFlw-up (Follow-up): Six months after surgery.

fFlw-up (Follow-up): One year after surgery.